| Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative SK Malladi, UR Patel, RS Rajmani, R Singh, S Pandey, S Kumar, ... ACS Infectious Diseases 7 (8), 2546-2564, 2021 | 33 | 2021 |
| A stabilized, monomeric, receptor binding domain elicits high-titer neutralizing antibodies against all SARS-CoV-2 variants of concern S Ahmed, MS Khan, S Gayathri, R Singh, S Kumar, UR Patel, SK Malladi, ... Frontiers in immunology 12, 765211, 2021 | 19 | 2021 |
| A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein B Khatri, I Pramanick, SK Malladi, RS Rajmani, S Kumar, P Ghosh, ... Nature Chemical Biology 18 (10), 1046-1055, 2022 | 12 | 2022 |
| A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2 A Sarkar, S Paul, C Singh, N Chowdhury, P Nag, S Das, S Kumar, ... Virus research 315, 198768, 2022 | 10 | 2022 |
| Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity S Kumar, R Delipan, D Chakraborty, K Kanjo, R Singh, N Singh, ... Journal of Virology 97 (11), e00922-23, 2023 | 6 | 2023 |
| Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern S Khaleeq, N Sengupta, S Kumar, UR Patel, RS Rajmani, P Reddy, ... Viruses 15 (2), 346, 2023 | 6 | 2023 |
| Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor MN Akhtar, S Kumar, P Sen Mbio 13 (4), e03309-21, 2022 | 5 | 2022 |
| Brevicillin, a novel lanthipeptide from the genus Brevibacillus with antimicrobial, antifungal, and antiviral activity SS Singh, D Sharma, C Singh, S Kumar, P Singh, A Sharma, DK Das, ... Journal of Applied Microbiology 134 (3), lxad054, 2023 | 2 | 2023 |
| Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and … N Kumar, IM Taily, C Singh, S Kumar, RS Rajmani, D Chakraborty, ... PLoS Pathogens 19 (5), e1011358, 2023 | 1 | 2023 |
| Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice MS Khan, V Jakob, R Singh, RS Rajmani, S Kumar, C Lemoine, ... Pharmaceutics 15 (12), 2759, 2023 | | 2023 |
| Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants N Mittal, S Kumar, RS Rajmani, R Singh, C Lemoine, V Jakob, S Bj, ... npj Vaccines 8 (1), 161, 2023 | | 2023 |
| A broadly protective CHO cell expressed recombinant spike protein subunit vaccine (IMT-CVAX) against SARS-CoV-2 Jitender, BV Kumar, S Singh, G Verma, R Kumar, PM Mishra, S Kumar, ... bioRxiv, 2023.04. 03.534161, 2023 | | 2023 |
| Enhanced protective efficacy of a novel, thermostable, RBD-S2 vaccine formulation against SARS-CoV-2 and its variants N Mittal, S Kumar, RS Rajmani, R Singh, C Lemoine, V Jakob, S BJ, ... bioRxiv, 2023.03. 19.533338, 2023 | | 2023 |
| Identification of diphenylurea derivatives as novel endocytosis inIdentification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum … N Kumar, IM Taily, C Singh, S Kumar, RS Rajmani, D Chakraborty, ... PLoS Pathogens 19 (5), 2023 | | 2023 |
